Literature DB >> 3096341

Human synovial fibroblasts produce urokinase-type plasminogen activator.

R L Medcalf, J A Hamilton.   

Abstract

The plasminogen activator produced by cultured human synovial fibroblasts was investigated both biochemically and immunologically. Stimulated either by all-trans-retinoic acid or by monocyte-conditioned medium, these fibroblasts elaborated a plasminogen activator with electrophoretic mobility similar to that of urokinase (Mr = 52 kilodaltons), and which also had immunologic cross-reactivity with urokinase. The plasminogen activator found in rheumatoid synovial fluids has been shown to be of the urokinase type. The findings reported here are consistent with the notion that synovial fibroblasts are a source of this proteinase.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3096341     DOI: 10.1002/art.1780291113

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  8 in total

Review 1.  Reactive oxygen species and bacterial biofilms in diabetic wound healing.

Authors:  Aksone Nouvong; Aaron M Ambrus; Ellen R Zhang; Lucas Hultman; Hilary A Coller
Journal:  Physiol Genomics       Date:  2016-10-07       Impact factor: 3.107

2.  The plasminogen activator/plasmin system is essential for development of the joint inflammatory phase of collagen type II-induced arthritis.

Authors:  Jinan Li; Annelii Ny; Göran Leonardsson; Kutty Selva Nandakumar; Rikard Holmdahl; Tor Ny
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

3.  Transforming growth factor beta stimulates urokinase-type plasminogen activator and DNA synthesis, but not prostaglandin E2 production, in human synovial fibroblasts.

Authors:  J A Hamilton; D S Piccoli; T Leizer; D M Butler; M Croatto; A K Royston
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

4.  Diverse morphological responses of normal human synovial fibroblasts to mononuclear leukocyte products: relationship to prostaglandin production and plasminogen activator activities, and comparison with the effects of purified interleukin 1.

Authors:  B J Clarris; T Leizer; J R Fraser; J A Hamilton
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

5.  Plasminogen activators in synovial fluid and plasma from patients with arthritis.

Authors:  E J Brommer; G Dooijewaard; B A Dijkmans; F C Breedveld
Journal:  Ann Rheum Dis       Date:  1992-08       Impact factor: 19.103

6.  Urokinase, a constitutive component of the inflamed synovial fluid, induces arthritis.

Authors:  Tao Jin; Andrej Tarkowski; Peter Carmeliet; Maria Bokarewa
Journal:  Arthritis Res Ther       Date:  2002-10-17       Impact factor: 5.156

Review 7.  Profile of Matrix-Remodeling Proteinases in Osteoarthritis: Impact of Fibronectin.

Authors:  Selene Pérez-García; Mar Carrión; Irene Gutiérrez-Cañas; Raúl Villanueva-Romero; David Castro; Carmen Martínez; Isidoro González-Álvaro; Francisco J Blanco; Yasmina Juarranz; Rosa P Gomariz
Journal:  Cells       Date:  2019-12-22       Impact factor: 6.600

Review 8.  Development and Testing of Thrombolytics in Stroke.

Authors:  Dmitri Nikitin; Seungbum Choi; Jan Mican; Martin Toul; Wi-Sun Ryu; Jiri Damborsky; Robert Mikulik; Dong-Eog Kim
Journal:  J Stroke       Date:  2021-01-31       Impact factor: 6.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.